Candidate for the stated function. Confirm substrate, formulation, reaction conditions and application before substitution.
Pack sizes & catalog numbers
See manufacturer · EM167AF
PRODUCT OVERVIEW
Compare with context
EXPLORE YOUR OPTIONS
3 cross-manufacturer candidates and 0 same-manufacturer related products.
These products share a candidate substitution group. Interchangeability has not yet been validated against all experimental requirements. Check the listed selection criteria before switching.
RNA capping / Cap 2′-O-methyltransferases
Vaccinia VP39 converts Cap-0 RNA to Cap-1 using SAM; requires an already capped substrate. Candidate for this workflow; confirm formulation, substrate and protocol compatibility before substitution.
RNA capping / Cap 2′-O-methyltransferases
Classification is based on the supplied product name. Confirm formulation, application and compatibility in the manufacturer documentation.
RNA capping / Cap 2′-O-methyltransferases
Vaccinia cap 2-prime-O-methyltransferase for methylation of capped RNA; capping enzyme is a separate component. Candidate for the listed workflow; compare buffer, sample input and protocol requirements before substitution.
Broader catalog resources for this branch. These links are discovery starting points, not verified replacements for individual products.
FROM THE LAB
Be the first to share your experience.
Ratings reflect user-reported experience, not independent performance testing or verified purchases. Reviews are never seeded or generated.
Create a researcher profile to rate products and share application-specific feedback.
Join the research communityTRACE THE EVIDENCE
Official product selector identifies EM167AF as standalone Vaccinia mRNA Cap 2-prime-O-Methyltransferase; EO166AF is separately cataloged Vaccinia Capping Enzyme.
Primary classification is an editorial interpretation of the product name and cited source. Technical equivalence is not established by category membership. Read our methodology.